The global Internal Neuromodulation market was valued at US$ 2102 million in 2023 and is anticipated to reach US$ 3542.4 million by 2030, witnessing a CAGR of 7.6% during the forecast period 2024-2030.

Internal Neuromodulation Market

Neuromodulation is used to regulate functions of nervous system, such as therapeutic alteration, inhibition, stimulation, modification, and others. There are two types of neuromodulation external neuromodulation and internal neuromodulation. Internal neuromodulation block or repair neuron signals of pain from reaching the brain using electrical impulses. These devices reduce highest levels of pain for various chronic or refractory diseases. Its clinical significance in pain reduction and therapeutics has lead a wide acceptance in the North American region.

The driving factors of the internal neuromodulation market are rising prevalence of neurological disorders, increase in the aging population, strong product pipeline, expanded target applications and new indications, and investments and funds. Moreover, technological advancements present opportunities for growth of the market.

This report aims to provide a comprehensive presentation of the global market for Internal Neuromodulation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Internal Neuromodulation.

Report Scope

The Internal Neuromodulation market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Internal Neuromodulation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Internal Neuromodulation companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Internal Neuromodulation Market Report

Report Metric	Details
Report Name	Internal Neuromodulation Market
Accounted market size in 2023	US$ 2102 million
Forecasted market size in 2030	US$ 3542.4 million
CAGR	7.6%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Spinal Cord Stimulator Deep Brain Stimulator Sacral Nerve Stimulator Vagus Nerve Stimulator Gastric Neuro Stimulator
Segment by Application	Parkinsons Disease Chronic Pain Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Medtronic PLC, Abbott, Boston Scientific Corp., Cerbomed GMBH, Cyberonics, Biocontrol Medical, Depuy Synthes Companies, Enteromedics, Synapse Biomedical, Uroplasty, Greatbatch, Abbott Laboratories, Nevro Corporation, NeuroSigma, MicroTransponder, Neuronetics, LivaNova PLC, Bioventus Inc, NeuroPace Inc
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Internal Neuromodulation companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Internal Neuromodulation Market growing?

Ans: The Internal Neuromodulation Market witnessing a CAGR of 7.6% during the forecast period 2024-2030.

What is the Internal Neuromodulation Market size in 2030?

Ans: The Internal Neuromodulation Market size in 2030 will be US$ 3542.4 million.

Who are the main players in the Internal Neuromodulation Market report?

Ans: The main players in the Internal Neuromodulation Market are Medtronic PLC, Abbott, Boston Scientific Corp., Cerbomed GMBH, Cyberonics, Biocontrol Medical, Depuy Synthes Companies, Enteromedics, Synapse Biomedical, Uroplasty, Greatbatch, Abbott Laboratories, Nevro Corporation, NeuroSigma, MicroTransponder, Neuronetics, LivaNova PLC, Bioventus Inc, NeuroPace Inc

What are the Application segmentation covered in the Internal Neuromodulation Market report?

Ans: The Applications covered in the Internal Neuromodulation Market report are Parkinsons Disease, Chronic Pain, Others

What are the Type segmentation covered in the Internal Neuromodulation Market report?

Ans: The Types covered in the Internal Neuromodulation Market report are Spinal Cord Stimulator, Deep Brain Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator, Gastric Neuro Stimulator

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Internal Neuromodulation Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Spinal Cord Stimulator

1.2.3 Deep Brain Stimulator

1.2.4 Sacral Nerve Stimulator

1.2.5 Vagus Nerve Stimulator

1.2.6 Gastric Neuro Stimulator

1.3 Market by Application

1.3.1 Global Internal Neuromodulation Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Parkinsons Disease

1.3.3 Chronic Pain

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Internal Neuromodulation Market Perspective (2019-2030)

2.2 Internal Neuromodulation Growth Trends by Region

2.2.1 Global Internal Neuromodulation Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Internal Neuromodulation Historic Market Size by Region (2019-2024)

2.2.3 Internal Neuromodulation Forecasted Market Size by Region (2025-2030)

2.3 Internal Neuromodulation Market Dynamics

2.3.1 Internal Neuromodulation Industry Trends

2.3.2 Internal Neuromodulation Market Drivers

2.3.3 Internal Neuromodulation Market Challenges

2.3.4 Internal Neuromodulation Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Internal Neuromodulation Players by Revenue

3.1.1 Global Top Internal Neuromodulation Players by Revenue (2019-2024)

3.1.2 Global Internal Neuromodulation Revenue Market Share by Players (2019-2024)

3.2 Global Internal Neuromodulation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Internal Neuromodulation Revenue

3.4 Global Internal Neuromodulation Market Concentration Ratio

3.4.1 Global Internal Neuromodulation Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Internal Neuromodulation Revenue in 2023

3.5 Internal Neuromodulation Key Players Head office and Area Served

3.6 Key Players Internal Neuromodulation Product Solution and Service

3.7 Date of Enter into Internal Neuromodulation Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Internal Neuromodulation Breakdown Data by Type

4.1 Global Internal Neuromodulation Historic Market Size by Type (2019-2024)

4.2 Global Internal Neuromodulation Forecasted Market Size by Type (2025-2030)

5 Internal Neuromodulation Breakdown Data by Application

5.1 Global Internal Neuromodulation Historic Market Size by Application (2019-2024)

5.2 Global Internal Neuromodulation Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Internal Neuromodulation Market Size (2019-2030)

6.2 North America Internal Neuromodulation Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Internal Neuromodulation Market Size by Country (2019-2024)

6.4 North America Internal Neuromodulation Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Internal Neuromodulation Market Size (2019-2030)

7.2 Europe Internal Neuromodulation Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Internal Neuromodulation Market Size by Country (2019-2024)

7.4 Europe Internal Neuromodulation Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Internal Neuromodulation Market Size (2019-2030)

8.2 Asia-Pacific Internal Neuromodulation Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Internal Neuromodulation Market Size by Region (2019-2024)

8.4 Asia-Pacific Internal Neuromodulation Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Internal Neuromodulation Market Size (2019-2030)

9.2 Latin America Internal Neuromodulation Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Internal Neuromodulation Market Size by Country (2019-2024)

9.4 Latin America Internal Neuromodulation Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Internal Neuromodulation Market Size (2019-2030)

10.2 Middle East & Africa Internal Neuromodulation Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Internal Neuromodulation Market Size by Country (2019-2024)

10.4 Middle East & Africa Internal Neuromodulation Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Medtronic PLC

11.1.1 Medtronic PLC Company Detail

11.1.2 Medtronic PLC Business Overview

11.1.3 Medtronic PLC Internal Neuromodulation Introduction

11.1.4 Medtronic PLC Revenue in Internal Neuromodulation Business (2019-2024)

11.1.5 Medtronic PLC Recent Development

11.2 Abbott

11.2.1 Abbott Company Detail

11.2.2 Abbott Business Overview

11.2.3 Abbott Internal Neuromodulation Introduction

11.2.4 Abbott Revenue in Internal Neuromodulation Business (2019-2024)

11.2.5 Abbott Recent Development

11.3 Boston Scientific Corp.

11.3.1 Boston Scientific Corp. Company Detail

11.3.2 Boston Scientific Corp. Business Overview

11.3.3 Boston Scientific Corp. Internal Neuromodulation Introduction

11.3.4 Boston Scientific Corp. Revenue in Internal Neuromodulation Business (2019-2024)

11.3.5 Boston Scientific Corp. Recent Development

11.4 Cerbomed GMBH

11.4.1 Cerbomed GMBH Company Detail

11.4.2 Cerbomed GMBH Business Overview

11.4.3 Cerbomed GMBH Internal Neuromodulation Introduction

11.4.4 Cerbomed GMBH Revenue in Internal Neuromodulation Business (2019-2024)

11.4.5 Cerbomed GMBH Recent Development

11.5 Cyberonics

11.5.1 Cyberonics Company Detail

11.5.2 Cyberonics Business Overview

11.5.3 Cyberonics Internal Neuromodulation Introduction

11.5.4 Cyberonics Revenue in Internal Neuromodulation Business (2019-2024)

11.5.5 Cyberonics Recent Development

11.6 Biocontrol Medical

11.6.1 Biocontrol Medical Company Detail

11.6.2 Biocontrol Medical Business Overview

11.6.3 Biocontrol Medical Internal Neuromodulation Introduction

11.6.4 Biocontrol Medical Revenue in Internal Neuromodulation Business (2019-2024)

11.6.5 Biocontrol Medical Recent Development

11.7 Depuy Synthes Companies

11.7.1 Depuy Synthes Companies Company Detail

11.7.2 Depuy Synthes Companies Business Overview

11.7.3 Depuy Synthes Companies Internal Neuromodulation Introduction

11.7.4 Depuy Synthes Companies Revenue in Internal Neuromodulation Business (2019-2024)

11.7.5 Depuy Synthes Companies Recent Development

11.8 Enteromedics

11.8.1 Enteromedics Company Detail

11.8.2 Enteromedics Business Overview

11.8.3 Enteromedics Internal Neuromodulation Introduction

11.8.4 Enteromedics Revenue in Internal Neuromodulation Business (2019-2024)

11.8.5 Enteromedics Recent Development

11.9 Synapse Biomedical

11.9.1 Synapse Biomedical Company Detail

11.9.2 Synapse Biomedical Business Overview

11.9.3 Synapse Biomedical Internal Neuromodulation Introduction

11.9.4 Synapse Biomedical Revenue in Internal Neuromodulation Business (2019-2024)

11.9.5 Synapse Biomedical Recent Development

11.10 Uroplasty

11.10.1 Uroplasty Company Detail

11.10.2 Uroplasty Business Overview

11.10.3 Uroplasty Internal Neuromodulation Introduction

11.10.4 Uroplasty Revenue in Internal Neuromodulation Business (2019-2024)

11.10.5 Uroplasty Recent Development

11.11 Greatbatch

11.11.1 Greatbatch Company Detail

11.11.2 Greatbatch Business Overview

11.11.3 Greatbatch Internal Neuromodulation Introduction

11.11.4 Greatbatch Revenue in Internal Neuromodulation Business (2019-2024)

11.11.5 Greatbatch Recent Development

11.12 Abbott Laboratories

11.12.1 Abbott Laboratories Company Detail

11.12.2 Abbott Laboratories Business Overview

11.12.3 Abbott Laboratories Internal Neuromodulation Introduction

11.12.4 Abbott Laboratories Revenue in Internal Neuromodulation Business (2019-2024)

11.12.5 Abbott Laboratories Recent Development

11.13 Nevro Corporation

11.13.1 Nevro Corporation Company Detail

11.13.2 Nevro Corporation Business Overview

11.13.3 Nevro Corporation Internal Neuromodulation Introduction

11.13.4 Nevro Corporation Revenue in Internal Neuromodulation Business (2019-2024)

11.13.5 Nevro Corporation Recent Development

11.14 NeuroSigma

11.14.1 NeuroSigma Company Detail

11.14.2 NeuroSigma Business Overview

11.14.3 NeuroSigma Internal Neuromodulation Introduction

11.14.4 NeuroSigma Revenue in Internal Neuromodulation Business (2019-2024)

11.14.5 NeuroSigma Recent Development

11.15 MicroTransponder

11.15.1 MicroTransponder Company Detail

11.15.2 MicroTransponder Business Overview

11.15.3 MicroTransponder Internal Neuromodulation Introduction

11.15.4 MicroTransponder Revenue in Internal Neuromodulation Business (2019-2024)

11.15.5 MicroTransponder Recent Development

11.16 Neuronetics

11.16.1 Neuronetics Company Detail

11.16.2 Neuronetics Business Overview

11.16.3 Neuronetics Internal Neuromodulation Introduction

11.16.4 Neuronetics Revenue in Internal Neuromodulation Business (2019-2024)

11.16.5 Neuronetics Recent Development

11.17 LivaNova PLC

11.17.1 LivaNova PLC Company Detail

11.17.2 LivaNova PLC Business Overview

11.17.3 LivaNova PLC Internal Neuromodulation Introduction

11.17.4 LivaNova PLC Revenue in Internal Neuromodulation Business (2019-2024)

11.17.5 LivaNova PLC Recent Development

11.18 Bioventus Inc

11.18.1 Bioventus Inc Company Detail

11.18.2 Bioventus Inc Business Overview

11.18.3 Bioventus Inc Internal Neuromodulation Introduction

11.18.4 Bioventus Inc Revenue in Internal Neuromodulation Business (2019-2024)

11.18.5 Bioventus Inc Recent Development

11.19 NeuroPace Inc

11.19.1 NeuroPace Inc Company Detail

11.19.2 NeuroPace Inc Business Overview

11.19.3 NeuroPace Inc Internal Neuromodulation Introduction

11.19.4 NeuroPace Inc Revenue in Internal Neuromodulation Business (2019-2024)

11.19.5 NeuroPace Inc Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Boston Scientific Corp

Cerbomed

Cyberonics

Depuy Synthes Companies

List of Tables

Table 1. Global Internal Neuromodulation Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Spinal Cord Stimulator

Table 3. Key Players of Deep Brain Stimulator

Table 4. Key Players of Sacral Nerve Stimulator

Table 5. Key Players of Vagus Nerve Stimulator

Table 6. Key Players of Gastric Neuro Stimulator

Table 7. Global Internal Neuromodulation Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Internal Neuromodulation Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Internal Neuromodulation Market Size by Region (2019-2024) & (US$ Million)

Table 10. Global Internal Neuromodulation Market Share by Region (2019-2024)

Table 11. Global Internal Neuromodulation Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 12. Global Internal Neuromodulation Market Share by Region (2025-2030)

Table 13. Internal Neuromodulation Market Trends

Table 14. Internal Neuromodulation Market Drivers

Table 15. Internal Neuromodulation Market Challenges

Table 16. Internal Neuromodulation Market Restraints

Table 17. Global Internal Neuromodulation Revenue by Players (2019-2024) & (US$ Million)

Table 18. Global Internal Neuromodulation Market Share by Players (2019-2024)

Table 19. Global Top Internal Neuromodulation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Internal Neuromodulation as of 2023)

Table 20. Ranking of Global Top Internal Neuromodulation Companies by Revenue (US$ Million) in 2023

Table 21. Global 5 Largest Players Market Share by Internal Neuromodulation Revenue (CR5 and HHI) & (2019-2024)

Table 22. Key Players Headquarters and Area Served

Table 23. Key Players Internal Neuromodulation Product Solution and Service

Table 24. Date of Enter into Internal Neuromodulation Market

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Internal Neuromodulation Market Size by Type (2019-2024) & (US$ Million)

Table 27. Global Internal Neuromodulation Revenue Market Share by Type (2019-2024)

Table 28. Global Internal Neuromodulation Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 29. Global Internal Neuromodulation Revenue Market Share by Type (2025-2030)

Table 30. Global Internal Neuromodulation Market Size by Application (2019-2024) & (US$ Million)

Table 31. Global Internal Neuromodulation Revenue Market Share by Application (2019-2024)

Table 32. Global Internal Neuromodulation Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 33. Global Internal Neuromodulation Revenue Market Share by Application (2025-2030)

Table 34. North America Internal Neuromodulation Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. North America Internal Neuromodulation Market Size by Country (2019-2024) & (US$ Million)

Table 36. North America Internal Neuromodulation Market Size by Country (2025-2030) & (US$ Million)

Table 37. Europe Internal Neuromodulation Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. Europe Internal Neuromodulation Market Size by Country (2019-2024) & (US$ Million)

Table 39. Europe Internal Neuromodulation Market Size by Country (2025-2030) & (US$ Million)

Table 40. Asia-Pacific Internal Neuromodulation Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 41. Asia-Pacific Internal Neuromodulation Market Size by Region (2019-2024) & (US$ Million)

Table 42. Asia-Pacific Internal Neuromodulation Market Size by Region (2025-2030) & (US$ Million)

Table 43. Latin America Internal Neuromodulation Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Latin America Internal Neuromodulation Market Size by Country (2019-2024) & (US$ Million)

Table 45. Latin America Internal Neuromodulation Market Size by Country (2025-2030) & (US$ Million)

Table 46. Middle East & Africa Internal Neuromodulation Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 47. Middle East & Africa Internal Neuromodulation Market Size by Country (2019-2024) & (US$ Million)

Table 48. Middle East & Africa Internal Neuromodulation Market Size by Country (2025-2030) & (US$ Million)

Table 49. Medtronic PLC Company Detail

Table 50. Medtronic PLC Business Overview

Table 51. Medtronic PLC Internal Neuromodulation Product

Table 52. Medtronic PLC Revenue in Internal Neuromodulation Business (2019-2024) & (US$ Million)

Table 53. Medtronic PLC Recent Development

Table 54. Abbott Company Detail

Table 55. Abbott Business Overview

Table 56. Abbott Internal Neuromodulation Product

Table 57. Abbott Revenue in Internal Neuromodulation Business (2019-2024) & (US$ Million)

Table 58. Abbott Recent Development

Table 59. Boston Scientific Corp. Company Detail

Table 60. Boston Scientific Corp. Business Overview

Table 61. Boston Scientific Corp. Internal Neuromodulation Product

Table 62. Boston Scientific Corp. Revenue in Internal Neuromodulation Business (2019-2024) & (US$ Million)

Table 63. Boston Scientific Corp. Recent Development

Table 64. Cerbomed GMBH Company Detail

Table 65. Cerbomed GMBH Business Overview

Table 66. Cerbomed GMBH Internal Neuromodulation Product

Table 67. Cerbomed GMBH Revenue in Internal Neuromodulation Business (2019-2024) & (US$ Million)

Table 68. Cerbomed GMBH Recent Development

Table 69. Cyberonics Company Detail

Table 70. Cyberonics Business Overview

Table 71. Cyberonics Internal Neuromodulation Product

Table 72. Cyberonics Revenue in Internal Neuromodulation Business (2019-2024) & (US$ Million)

Table 73. Cyberonics Recent Development

Table 74. Biocontrol Medical Company Detail

Table 75. Biocontrol Medical Business Overview

Table 76. Biocontrol Medical Internal Neuromodulation Product

Table 77. Biocontrol Medical Revenue in Internal Neuromodulation Business (2019-2024) & (US$ Million)

Table 78. Biocontrol Medical Recent Development

Table 79. Depuy Synthes Companies Company Detail

Table 80. Depuy Synthes Companies Business Overview

Table 81. Depuy Synthes Companies Internal Neuromodulation Product

Table 82. Depuy Synthes Companies Revenue in Internal Neuromodulation Business (2019-2024) & (US$ Million)

Table 83. Depuy Synthes Companies Recent Development

Table 84. Enteromedics Company Detail

Table 85. Enteromedics Business Overview

Table 86. Enteromedics Internal Neuromodulation Product

Table 87. Enteromedics Revenue in Internal Neuromodulation Business (2019-2024) & (US$ Million)

Table 88. Enteromedics Recent Development

Table 89. Synapse Biomedical Company Detail

Table 90. Synapse Biomedical Business Overview

Table 91. Synapse Biomedical Internal Neuromodulation Product

Table 92. Synapse Biomedical Revenue in Internal Neuromodulation Business (2019-2024) & (US$ Million)

Table 93. Synapse Biomedical Recent Development

Table 94. Uroplasty Company Detail

Table 95. Uroplasty Business Overview

Table 96. Uroplasty Internal Neuromodulation Product

Table 97. Uroplasty Revenue in Internal Neuromodulation Business (2019-2024) & (US$ Million)

Table 98. Uroplasty Recent Development

Table 99. Greatbatch Company Detail

Table 100. Greatbatch Business Overview

Table 101. Greatbatch Internal Neuromodulation Product

Table 102. Greatbatch Revenue in Internal Neuromodulation Business (2019-2024) & (US$ Million)

Table 103. Greatbatch Recent Development

Table 104. Abbott Laboratories Company Detail

Table 105. Abbott Laboratories Business Overview

Table 106. Abbott Laboratories Internal Neuromodulation Product

Table 107. Abbott Laboratories Revenue in Internal Neuromodulation Business (2019-2024) & (US$ Million)

Table 108. Abbott Laboratories Recent Development

Table 109. Nevro Corporation Company Detail

Table 110. Nevro Corporation Business Overview

Table 111. Nevro Corporation Internal Neuromodulation Product

Table 112. Nevro Corporation Revenue in Internal Neuromodulation Business (2019-2024) & (US$ Million)

Table 113. Nevro Corporation Recent Development

Table 114. NeuroSigma Company Detail

Table 115. NeuroSigma Business Overview

Table 116. NeuroSigma Internal Neuromodulation Product

Table 117. NeuroSigma Revenue in Internal Neuromodulation Business (2019-2024) & (US$ Million)

Table 118. NeuroSigma Recent Development

Table 119. MicroTransponder Company Detail

Table 120. MicroTransponder Business Overview

Table 121. MicroTransponder Internal Neuromodulation Product

Table 122. MicroTransponder Revenue in Internal Neuromodulation Business (2019-2024) & (US$ Million)

Table 123. MicroTransponder Recent Development

Table 124. Neuronetics Company Detail

Table 125. Neuronetics Business Overview

Table 126. Neuronetics Internal Neuromodulation Product

Table 127. Neuronetics Revenue in Internal Neuromodulation Business (2019-2024) & (US$ Million)

Table 128. Neuronetics Recent Development

Table 129. LivaNova PLC Company Detail

Table 130. LivaNova PLC Business Overview

Table 131. LivaNova PLC Internal Neuromodulation Product

Table 132. LivaNova PLC Revenue in Internal Neuromodulation Business (2019-2024) & (US$ Million)

Table 133. LivaNova PLC Recent Development

Table 134. Bioventus Inc Company Detail

Table 135. Bioventus Inc Business Overview

Table 136. Bioventus Inc Internal Neuromodulation Product

Table 137. Bioventus Inc Revenue in Internal Neuromodulation Business (2019-2024) & (US$ Million)

Table 138. Bioventus Inc Recent Development

Table 139. NeuroPace Inc Company Detail

Table 140. NeuroPace Inc Business Overview

Table 141. NeuroPace Inc Internal Neuromodulation Product

Table 142. NeuroPace Inc Revenue in Internal Neuromodulation Business (2019-2024) & (US$ Million)

Table 143. NeuroPace Inc Recent Development

Table 144. Research Programs/Design for This Report

Table 145. Key Data Information from Secondary Sources

Table 146. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Internal Neuromodulation Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Internal Neuromodulation Market Share by Type: 2023 VS 2030

Figure 3. Spinal Cord Stimulator Features

Figure 4. Deep Brain Stimulator Features

Figure 5. Sacral Nerve Stimulator Features

Figure 6. Vagus Nerve Stimulator Features

Figure 7. Gastric Neuro Stimulator Features

Figure 8. Global Internal Neuromodulation Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global Internal Neuromodulation Market Share by Application: 2023 VS 2030

Figure 10. Parkinsons Disease Case Studies

Figure 11. Chronic Pain Case Studies

Figure 12. Others Case Studies

Figure 13. Internal Neuromodulation Report Years Considered

Figure 14. Global Internal Neuromodulation Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global Internal Neuromodulation Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Internal Neuromodulation Market Share by Region: 2023 VS 2030

Figure 17. Global Internal Neuromodulation Market Share by Players in 2023

Figure 18. Global Top Internal Neuromodulation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Internal Neuromodulation as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by Internal Neuromodulation Revenue in 2023

Figure 20. North America Internal Neuromodulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America Internal Neuromodulation Market Share by Country (2019-2030)

Figure 22. United States Internal Neuromodulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Internal Neuromodulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Internal Neuromodulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Internal Neuromodulation Market Share by Country (2019-2030)

Figure 26. Germany Internal Neuromodulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. France Internal Neuromodulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. U.K. Internal Neuromodulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Italy Internal Neuromodulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Russia Internal Neuromodulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Nordic Countries Internal Neuromodulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Internal Neuromodulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Internal Neuromodulation Market Share by Region (2019-2030)

Figure 34. China Internal Neuromodulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Japan Internal Neuromodulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. South Korea Internal Neuromodulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Southeast Asia Internal Neuromodulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. India Internal Neuromodulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Australia Internal Neuromodulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Internal Neuromodulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Internal Neuromodulation Market Share by Country (2019-2030)

Figure 42. Mexico Internal Neuromodulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Brazil Internal Neuromodulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Internal Neuromodulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Internal Neuromodulation Market Share by Country (2019-2030)

Figure 46. Turkey Internal Neuromodulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Saudi Arabia Internal Neuromodulation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Medtronic PLC Revenue Growth Rate in Internal Neuromodulation Business (2019-2024)

Figure 49. Abbott Revenue Growth Rate in Internal Neuromodulation Business (2019-2024)

Figure 50. Boston Scientific Corp. Revenue Growth Rate in Internal Neuromodulation Business (2019-2024)

Figure 51. Cerbomed GMBH Revenue Growth Rate in Internal Neuromodulation Business (2019-2024)

Figure 52. Cyberonics Revenue Growth Rate in Internal Neuromodulation Business (2019-2024)

Figure 53. Biocontrol Medical Revenue Growth Rate in Internal Neuromodulation Business (2019-2024)

Figure 54. Depuy Synthes Companies Revenue Growth Rate in Internal Neuromodulation Business (2019-2024)

Figure 55. Enteromedics Revenue Growth Rate in Internal Neuromodulation Business (2019-2024)

Figure 56. Synapse Biomedical Revenue Growth Rate in Internal Neuromodulation Business (2019-2024)

Figure 57. Uroplasty Revenue Growth Rate in Internal Neuromodulation Business (2019-2024)

Figure 58. Greatbatch Revenue Growth Rate in Internal Neuromodulation Business (2019-2024)

Figure 59. Abbott Laboratories Revenue Growth Rate in Internal Neuromodulation Business (2019-2024)

Figure 60. Nevro Corporation Revenue Growth Rate in Internal Neuromodulation Business (2019-2024)

Figure 61. NeuroSigma Revenue Growth Rate in Internal Neuromodulation Business (2019-2024)

Figure 62. MicroTransponder Revenue Growth Rate in Internal Neuromodulation Business (2019-2024)

Figure 63. Neuronetics Revenue Growth Rate in Internal Neuromodulation Business (2019-2024)

Figure 64. LivaNova PLC Revenue Growth Rate in Internal Neuromodulation Business (2019-2024)

Figure 65. Bioventus Inc Revenue Growth Rate in Internal Neuromodulation Business (2019-2024)

Figure 66. NeuroPace Inc Revenue Growth Rate in Internal Neuromodulation Business (2019-2024)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions